MLTX vs. MMYT
Compare and contrast key facts about MoonLake Immunotherapeutics (MLTX) and MakeMyTrip Limited (MMYT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MLTX or MMYT.
Performance
MLTX vs. MMYT - Performance Comparison
Returns By Period
In the year-to-date period, MLTX achieves a -10.05% return, which is significantly lower than MMYT's 131.44% return.
MLTX
-10.05%
16.59%
32.97%
19.89%
N/A
N/A
MMYT
131.44%
9.67%
37.22%
156.08%
33.81%
14.22%
Fundamentals
| MLTX | MMYT | |
|---|---|---|
| Market Cap | $3.14B | $11.78B |
| EPS | -$1.27 | $1.90 |
| Total Revenue (TTM) | $39.48K | $882.62M |
| Gross Profit (TTM) | -$34.48K | $491.36M |
| EBITDA (TTM) | -$108.45M | $158.93M |
Key characteristics
| MLTX | MMYT | |
|---|---|---|
| Sharpe Ratio | 0.39 | 3.06 |
| Sortino Ratio | 0.91 | 3.25 |
| Omega Ratio | 1.11 | 1.44 |
| Calmar Ratio | 0.50 | 7.38 |
| Martin Ratio | 0.80 | 21.67 |
| Ulcer Index | 24.95% | 7.20% |
| Daily Std Dev | 50.77% | 51.02% |
| Max Drawdown | -64.60% | -73.45% |
| Current Drawdown | -14.94% | -4.16% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between MLTX and MMYT is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
MLTX vs. MMYT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for MoonLake Immunotherapeutics (MLTX) and MakeMyTrip Limited (MMYT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MLTX vs. MMYT - Dividend Comparison
Neither MLTX nor MMYT has paid dividends to shareholders.
Drawdowns
MLTX vs. MMYT - Drawdown Comparison
The maximum MLTX drawdown since its inception was -64.60%, smaller than the maximum MMYT drawdown of -73.45%. Use the drawdown chart below to compare losses from any high point for MLTX and MMYT. For additional features, visit the drawdowns tool.
Volatility
MLTX vs. MMYT - Volatility Comparison
The current volatility for MoonLake Immunotherapeutics (MLTX) is 15.02%, while MakeMyTrip Limited (MMYT) has a volatility of 17.58%. This indicates that MLTX experiences smaller price fluctuations and is considered to be less risky than MMYT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MLTX vs. MMYT - Financials Comparison
This section allows you to compare key financial metrics between MoonLake Immunotherapeutics and MakeMyTrip Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities